Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04461600
Title A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer (TENACITY)
Acronym TENACITY
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ayala Pharmaceuticals, Inc,
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR | GBR | ESP | BEL


No variant requirements are available.